BioXcel Therapeutics, Inc. (BTAI)
1.13
-0.01
(-0.88%)
USD |
NASDAQ |
May 22, 16:00
1.14
+0.01
(+0.88%)
After-Hours: 20:00
BioXcel Therapeutics Shareholders Equity (Quarterly) : -105.54M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Verastem, Inc. | 81.78M |
| Quince Therapeutics, Inc. | 15.67M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.02M |
| Total Liabilities (Quarterly) | 139.57M |
| Debt to Equity Ratio | -0.9502 |
| Current Ratio | 0.6166 |
| Net Debt Paydown Yield | 1.47% |